This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a coding update and a scientific overview.

This activity discusses the use of PSMA PET for staging in high-risk prostate cancer. This includes when to order a PSMA PET, how to interpret it, common pitfalls and controversies of the scans.

This activity briefly reviews the rationale to use radiation therapy to treat kidney cancers, including considerations for patient selection.

This journal activity provides practitioners with a comprehensive review of the data to date, as well as expert opinions, on the incorporation of genomic classifiers into prostate cancer risk stratification in clinical practice as well as future translational directions.

We will start with a brief review of anatomy in CT and MRI followed by a brief discussion of how to deliver a boost based on the FLAME trial. Then we will follow with a review of the postoperative contouring guidelines and the update to the pelvic lymph nodes contouring guidelines.

We will start with a brief review of anatomy in CT and MRI followed by a brief discussion of how to deliver a boost based on the FLAME trial. Then we will follow with a review of the postoperative contouring guidelines and the update to the pelvic lymph nodes contouring guidelines.

This refresher course will provide an overview of the treatment of prostate cancer with an emphasis on the role of radiation therapy in the treatment of localized disease, nodal disease, recurrent disease after prostatectomy, and treatment of the primary in the setting of oligometastatic disease.